Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Micro Fabrication (BMF), also known in corporate records as BMF Material Technology, is a private advanced-manufacturing company specializing in ultra-high-precision micro-scale 3D printing. The company’s core business is its proprietary Projection Micro Stereolithography (PµSL) platform, which is used to produce highly accurate parts for medical devices, life sciences, electronics, optics, photonics, and other precision applications. While BMF is not a therapeutics developer, it has meaningful healthcare exposure through dental and medtech applications, most notably its UltraThineer cosmetic dental veneer offering and related zirconia-based manufacturing workflow. BMF sells 3D-printing systems, materials, prototyping and production services, and increasingly supports commercial healthcare use cases through specialized labs and application development. Founded in 2016 as an MIT spinout, the company operates internationally with offices in the United States, China, and Japan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Micro Fabrication.